3D Printers to Produce Personalized Medicines

CurifyLabs and Natural Machines have entered a strategic partnership to develop a technology that enables customized medicine production through 3D printing – producing personalized medicines for human and veterinary patients, on-site in pharmacies and hospitals. Compounding is the manual preparation of individualized drug treatments for patients where an optimal treatment cannot be achieved with the currently available medicinal products. There are many talented pharmacists who are able to compound drugs manually but the process is ineffective and lacks quality control.

With this partnership, we are developing a unique Medicine-as-a-Service concept for pharmacy compounding and we believe that our partnership with Natural Machines will bring an affordable and superior 3D printing platform to the market. Together we can revolutionize the industry within personalized medicine offering localized, on-demand drug manufacturing.”, said Charlotta Topelius, CEO, CurifyLabs. This partnership aims to develop a unique solution that optimizes and automates the compounding process in pharmacies and hospitals, by utilizing 3D printers. CurifyLabs will commercialize the solution on a global scale. The two companies aim to introduce the technology to the market globally during 2022.

Our initial pilots have proved the potential to print personalized medicines based on CurifyLabs’ pharmaceutical formulations. We continue to focus on adapting the technology to establish a new approach for personalized medicine for our customers, based on pharma grade ingredients and integrated quality control”, said Niklas Sandler Topelius, Chief Scientific Officer, CurifyLabs.

Our partnership with CurifyLabs will help us to grow our portfolio. At Natural Machines, we have solutions for the food sector and the personal care industry, and now with this strategic partnership, we add the pharmaceutical field. This partnership will leverage both CurifyLabs’ experience and latest developments in pharma with our extensive 3D printing expertise, providing a new solution that aligns with the growing global trend of product personalization,” said Lynette Kucsma, founder and CMO of Natural Machines.

Source: https://www.3dprintingmedia.network/

New copper surface eliminates bacteria in just two minutes

A new surface that kills bacteria more than 100 times faster and more effectively than standard copper could help combat the growing threat of antibiotic-resistant superbugs. The new copper product is the result of a collaborative research project with RMIT University and Australia’s national science agency, CSIRO, with findings just published in Biomaterials. Copper has long been used to fight different strains of bacteria, including the commonly found golden staph, because the ions released from the metal’s surface are toxic to bacterial cells. But this process is slow when standard copper is used, as RMIT University’s Distinguished Professor Ma Qian explained, and significant efforts are underway by researchers worldwide to speed it up.

The copper magnified 500,000 times under a scanning electron microscope shows the tiny nano-scale pores in the structure

A standard copper surface will kill about 97% of golden staph within four hours,” Qian said. “Incredibly, when we placed golden staph bacteria on our specially-designed copper surface, it destroyed more than 99.99% of the cells in just two minutes.” “So not only is it more effective, it’s 120 times faster.” Importantly, said Qian, these results were achieved without the assistance of any drug. “Our copper structure has shown itself to be remarkably potent for such a common material,” he said.

The team believes there could be a huge range of applications for the new material once further developed, including antimicrobial doorhandles and other touch surfaces in schools, hospitals, homes and public transport, as well as filters in antimicrobial respirators or air ventilation systems, and in face masks. The team is now looking to investigate the enhanced copper’s effectiveness against SARS-COV-2, the virus that causes COVID-19, including assessing 3D-printed samples. Other studies suggest copper may be highly effective against the virus, leading the US Environmental Protection Agency to officially approve copper surfaces for antiviral uses earlier this year.

Source: https://www.rmit.edu.au/news/